Approval · Notice of Compliance 1134 · 2000
ENBREL: Notice of Compliance 1134
Issued December 1, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1134
- Date
- December 1, 2000
- Company
- Immunex CorporationThousand Oaks, California, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENBREL | 02242903 | Cancelled Post Market |
Medicinal ingredients
- ETANERCEPT 25 MG per KIT